A discussion of the rapid integration of AI in the US insurance industry, the legal and ethical challenges arising from AI ...

Amazon can steer market-wide prices without ever colluding—exposing a gap in antitrust law that the FTC is now fighting to ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report first quarter 2026 financial results and provide a ...

During their bulletin they made great play of the fact that the Reform UK leader in Scotland, Malcolm Offord, claimed to be the owner of six houses, six boats and five cars. They knew this would be ...

After using Lenovo's new Yoga laptop, I'm wondering if Windows makers are running out of ideas ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced the commencement of trading of its ordinary shares on The Nasdaq Global Select Market (Nasdaq), replacing the listing of American Depositary Shares ...

The dismantling of public health through NIH funding cuts, CDC censorship and Medicaid rollbacks is a deliberate attack on ...

Good morning, and welcome to Carrier's First Quarter 2026 Earnings Conference Call. I would like to introduce you to today's host for the conference, Michael Rednor, Vice President of Investor ...

VerticalScope looks deeply undervalued: margin gains and strong free cash flow despite MAU declines. Click here to find out ...

Dax Zey was born on January 1, 2026. It was Herasight’s 11th baby, and Chase and Arthur’s first. He was as healthy as his ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has called all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2028 (the “notes”) (CUSIP No.

How to preserve energy, delegate effectively, and stay connected to what matters most, without burning out. “Founder mode” ...